The Aim The Study: To analyze the density of the mandible in cancer patients during treatment with zoledronic acid.
Materials And Methods: A retrospective cohort study included 45 patients with cancer aged 26-81 years (average age 55±12.88 years), of whom 14 patients had bone metastases (=14) and took 4 mg of zolendronic acid once every 28 days.